<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37760965</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 and Parkinson's Disease: A Review of Where We Are Now.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2524</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines11092524</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has been discussed in the context of Parkinson's disease (PD) over the last three years. Now that we are entering the long-term phase of this pandemic, we are intrigued to look back and see how and why the community of patients with PD was impacted and what knowledge we have collected so far. The relationship between COVID-19 and PD is likely multifactorial in nature. Similar to other systemic infections, a probable worsening of PD symptoms secondary to COVID-19, either transient or persistent (long COVID), has been demonstrated, while the COVID-19-related mortality of PD patients may be increased compared to the general population. These observations could be attributed to direct or indirect damage from SARS-CoV-2 in the central nervous system (CNS) or could result from general infection-related parameters (e.g., hospitalization or drugs) and the sequelae of the COVID-19 pandemic (e.g., quarantine). A growing number of cases of new-onset parkinsonism or PD following SARS-CoV-2 infection have been reported, either closely (post-infectious) or remotely (para-infectious) after a COVID-19 diagnosis, although such a link remains hypothetical. The pathophysiological substrate of these phenomena remains elusive; however, research studies, particularly pathology studies, have suggested various COVID-19-induced degenerative changes with potential associations with PD/parkinsonism. We review the literature to date for answers considering the relationship between SARS-CoV-2 infection and PD/parkinsonism, examining pathophysiology, clinical manifestations, vaccination, and future directions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boura</LastName><ForeName>Iro</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Parkinson's Foundation Centre of Excellence, King's College Hospital, Denmark Hill, London SE5 9RS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Basic and Clinical Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5 Cutcombe Road, London SE5 9RX, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, University of Crete, Heraklion, 71003 Iraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qamar</LastName><ForeName>Mubasher A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-4105-5097</Identifier><AffiliationInfo><Affiliation>Parkinson's Foundation Centre of Excellence, King's College Hospital, Denmark Hill, London SE5 9RS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Basic and Clinical Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5 Cutcombe Road, London SE5 9RX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daddoveri</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0009-0001-2706-6697</Identifier><AffiliationInfo><Affiliation>Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Via Savi 10, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leta</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Parkinson's Foundation Centre of Excellence, King's College Hospital, Denmark Hill, London SE5 9RS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Basic and Clinical Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5 Cutcombe Road, London SE5 9RX, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Parkinson and Movement Disorders Unit, Department of Clinical Neuroscience, Fondazione, IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poplawska-Domaszewicz</LastName><ForeName>Karolina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Poznan University of Medical Sciences, 60-355 Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falup-Pecurariu</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7394-7161</Identifier><AffiliationInfo><Affiliation>Department of Neurology, County Clinic Hospital, Faculty of Medicine, Transilvania University Brasov, 500019 Brasov, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ray Chaudhuri</LastName><ForeName>K</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2815-0505</Identifier><AffiliationInfo><Affiliation>Parkinson's Foundation Centre of Excellence, King's College Hospital, Denmark Hill, London SE5 9RS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Basic and Clinical Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5 Cutcombe Road, London SE5 9RX, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">parkinsonism</Keyword><Keyword MajorTopicYN="N">pathophysiology</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37760965</ArticleId><ArticleId IdType="pmc">PMC10526287</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11092524</ArticleId><ArticleId IdType="pii">biomedicines11092524</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ali S.S., Mumtaz A., Qamar M.A., Tebha S.S., Parhin A., Butt M., Essar M.Y. New-onset Parkinsonism as a COVID-19 infection sequela: A systematic review and meta-analysis. Ann. Med. Surg. 2022;80:104281. doi: 10.1016/j.amsu.2022.104281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.104281</ArticleId><ArticleId IdType="pmc">PMC9359766</ArticleId><ArticleId IdType="pubmed">35971509</ArticleId></ArticleIdList></Reference><Reference><Citation>Boura I., Chaudhuri K.R. Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far. Mov. Disord. Clin. Pract. 2022;9:584&#x2013;593. doi: 10.1002/mdc3.13461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.13461</ArticleId><ArticleId IdType="pmc">PMC9111006</ArticleId><ArticleId IdType="pubmed">35601258</ArticleId></ArticleIdList></Reference><Reference><Citation>Leta V., Urso D., Batzu L., Lau Y.H., Mathew D., Boura I., Raeder V., Falup-Pecurariu C., van Wamelen D., Ray Chaudhuri K. Viruses, parkinsonism and Parkinson&#x2019;s disease: The past, present and future. J. Neural Transm. 2022;129:1119&#x2013;1132. doi: 10.1007/s00702-022-02536-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-022-02536-y</ArticleId><ArticleId IdType="pmc">PMC9422946</ArticleId><ArticleId IdType="pubmed">36036863</ArticleId></ArticleIdList></Reference><Reference><Citation>Leta V., Boura I., van Wamelen D.J., Rodriguez-Violante M., Antonini A., Chaudhuri K.R. COVID-19 and Parkinson&#x2019;s disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism. Int. Rev. Neurobiol. 2022;165:63&#x2013;89. doi: 10.1016/bs.irn.2022.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2022.04.004</ArticleId><ArticleId IdType="pmc">PMC9357514</ArticleId><ArticleId IdType="pubmed">36208907</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon D.K., Tanner C.M., Brundin P. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin. Geriatr. Med. 2020;36:1&#x2013;12. doi: 10.1016/j.cger.2019.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2019.08.002</ArticleId><ArticleId IdType="pmc">PMC6905381</ArticleId><ArticleId IdType="pubmed">31733690</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestrino R., Schapira A.H.V. Parkinson disease. Eur. J. Neurol. 2020;27:27&#x2013;42. doi: 10.1111/ene.14108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14108</ArticleId><ArticleId IdType="pubmed">31631455</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.Y., Martin-Bastida A., Murueta-Goyena A., Gabilondo I., Cuenca N., Piccini P., Jeon B. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease. Nat. Rev. Neurol. 2022;18:203&#x2013;220. doi: 10.1038/s41582-022-00618-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-022-00618-9</ArticleId><ArticleId IdType="pubmed">35177849</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen L.K., Dowd E., McKernan D.P. A role for viral infections in Parkinson&#x2019;s etiology? Neuronal Signal. 2018;2:Ns20170166. doi: 10.1042/NS20170166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/NS20170166</ArticleId><ArticleId IdType="pmc">PMC7373231</ArticleId><ArticleId IdType="pubmed">32714585</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H., Boltz D.A., Webster R.G., Smeyne R.J. Viral parkinsonism. Biochim. Biophys. Acta. 2009;1792:714&#x2013;721. doi: 10.1016/j.bbadis.2008.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2008.08.001</ArticleId><ArticleId IdType="pmc">PMC4642437</ArticleId><ArticleId IdType="pubmed">18760350</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu X.L., Wang X., Xiang Y., Shen L.L., Wang Q.H., Liu Y.H., Jiao S.S., Wang Y.R., Cao H.Y., Yi X., et al. The association between infectious burden and Parkinson&#x2019;s disease: A case-control study. Park. Relat. Disord. 2015;21:877&#x2013;881. doi: 10.1016/j.parkreldis.2015.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2015.05.015</ArticleId><ArticleId IdType="pubmed">26037459</ArticleId></ArticleIdList></Reference><Reference><Citation>Woulfe J.M., Duke R., Middeldorp J.M., Stevens S., Vervoort M., Hashimoto M., Masliah E., Chan P., Di Monte D.A., Langston J.W., et al. Absence of elevated anti-alpha-synuclein and anti-EBV latent membrane protein antibodies in PD. Neurology. 2002;58:1435&#x2013;1436. doi: 10.1212/WNL.58.9.1435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.58.9.1435</ArticleId><ArticleId IdType="pubmed">12011302</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Zuo Y., Jiang L., Peng Y., Huang X., Zuo L. Epstein-Barr Virus and Neurological Diseases. Front. Mol. Biosci. 2021;8:816098. doi: 10.3389/fmolb.2021.816098.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.816098</ArticleId><ArticleId IdType="pmc">PMC8784775</ArticleId><ArticleId IdType="pubmed">35083281</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVaughn S., M&#xfc;ller-Oehring E.M., Markey B., Bront&#xeb;-Stewart H.M., Schulte T. Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention&#x2014;A Comparison with Parkinson&#x2019;s Disease. Neuropsychol. Rev. 2015;25:424&#x2013;438. doi: 10.1007/s11065-015-9305-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-015-9305-x</ArticleId><ArticleId IdType="pmc">PMC5519342</ArticleId><ArticleId IdType="pubmed">26577508</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattos J.P.d., Rosso A.L.Z.d., Corr&#xea;a R.B., Novis S.A. Movement disorders in 28 HIV-infected patients. Arq. Neuro-Psiquiatr. 2002;60:525&#x2013;530. doi: 10.1590/S0004-282X2002000400002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-282X2002000400002</ArticleId><ArticleId IdType="pubmed">12244384</ArticleId></ArticleIdList></Reference><Reference><Citation>Clifford D.B. Human Immunodeficiency Virus&#x2014;Associated Dementia. Arch. Neurol. 2000;57:321&#x2013;324. doi: 10.1001/archneur.57.3.321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.57.3.321</ArticleId><ArticleId IdType="pubmed">10714656</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H.Y., Mai T.H., Kim K.A., Cho H., Ki M. Association between viral hepatitis infection and Parkinson&#x2019;s disease: A population-based prospective study. J. Viral Hepat. 2020;27:1171&#x2013;1178. doi: 10.1111/jvh.13346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvh.13346</ArticleId><ArticleId IdType="pubmed">32558154</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeyne R.J., Noyce A.J., Byrne M., Savica R., Marras C. Infection and Risk of Parkinson&#x2019;s Disease. J. Parkinson&#x2019;s Dis. 2021;11:31&#x2013;43. doi: 10.3233/JPD-202279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202279</ArticleId><ArticleId IdType="pmc">PMC7990414</ArticleId><ArticleId IdType="pubmed">33361610</ArticleId></ArticleIdList></Reference><Reference><Citation>Toovey S., Jick S.S., Meier C.R. Parkinson&#x2019;s disease or Parkinson symptoms following seasonal influenza. Influenza Other Respir. Viruses. 2011;5:328&#x2013;333. doi: 10.1111/j.1750-2659.2011.00232.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-2659.2011.00232.x</ArticleId><ArticleId IdType="pmc">PMC4942044</ArticleId><ArticleId IdType="pubmed">21668692</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocoros N.M., Svensson E., Sz&#xe9;pligeti S.K., Vestergaard S.V., Szentk&#xfa;ti P., Thomsen R.W., Borghammer P., S&#xf8;rensen H.T., Henderson V.W. Long-term Risk of Parkinson Disease Following Influenza and Other Infections. JAMA Neurol. 2021;78:1461&#x2013;1470. doi: 10.1001/jamaneurol.2021.3895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.3895</ArticleId><ArticleId IdType="pmc">PMC8546623</ArticleId><ArticleId IdType="pubmed">34694344</ArticleId></ArticleIdList></Reference><Reference><Citation>Baizabal-Carvallo J.F., Alonso-Juarez M. The role of viruses in the pathogenesis of Parkinson&#x2019;s disease. Neural Regen. Res. 2021;16:1200&#x2013;1201. doi: 10.4103/1673-5374.300437.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.300437</ArticleId><ArticleId IdType="pmc">PMC8224138</ArticleId><ArticleId IdType="pubmed">33269775</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T., Li G., Xu J., Gao S., Chen X. The Challenge of the Pathogenesis of Parkinson&#x2019;s Disease: Is Autoimmunity the Culprit? Front. Immunol. 2018;9:2047. doi: 10.3389/fimmu.2018.02047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02047</ArticleId><ArticleId IdType="pmc">PMC6170625</ArticleId><ArticleId IdType="pubmed">30319601</ArticleId></ArticleIdList></Reference><Reference><Citation>Calculli A., Bocci T., Porcino M., Avenali M., Casellato C., Arceri S., Regalbuto S., Priori A., Pisani A. Parkinson disease following COVID-19: Report of six cases. Eur. J. Neurol. 2023;30:1272&#x2013;1280. doi: 10.1111/ene.15732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15732</ArticleId><ArticleId IdType="pubmed">36807419</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider S.A., Desai S., Phokaewvarangkul O., Rosca E.C., Sringean J., Anand P., Bravo G.&#xc1;., Cardoso F., Cervantes-Arslanian A.M., Chovatiya H., et al. COVID19-associated new-onset movement disorders: A follow-up study. J. Neurol. 2023;270:2409&#x2013;2415. doi: 10.1007/s00415-023-11661-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-023-11661-x</ArticleId><ArticleId IdType="pmc">PMC10029788</ArticleId><ArticleId IdType="pubmed">36943516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitarnun W., Apiwattanakul M., Thodthasri T., Tantisungvarakoon P., Pangwong W. Steroid administration for post-COVID-19 Parkinsonism: A case report. Neurol. Clin. Neurosci. 2023;11:49&#x2013;51. doi: 10.1111/ncn3.12679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ncn3.12679</ArticleId><ArticleId IdType="pmc">PMC9874587</ArticleId><ArticleId IdType="pubmed">36714458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh R., Ray A., Roy D., Das S., Dubey S., Benito-Le&#xf3;n J. Parkinsonism with akinetic mutism following osmotic demyelination syndrome in a SARS-CoV-2 infected elderly diabetic woman: A case report. Neurologia. 2021;37:706. doi: 10.1016/j.nrl.2021.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2021.09.007</ArticleId><ArticleId IdType="pmc">PMC9526005</ArticleId><ArticleId IdType="pubmed">36195379</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacinto S., Latorre A., Magrinelli F., Bhatia K.P. Parkinsonism Following SARS-CoV-2 Infection Unmasks a Genetic Twist. Mov. Disord. Clin. Pract. 2023;10:1146&#x2013;1149. doi: 10.1002/mdc3.13785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.13785</ArticleId><ArticleId IdType="pmc">PMC10354609</ArticleId><ArticleId IdType="pubmed">37476306</ArticleId></ArticleIdList></Reference><Reference><Citation>Morassi M., Palmerini F., Nici S., Magni E., Savelli G., Guerra U.P., Chieregato M., Morbelli S., Vogrig A. SARS-CoV-2-related encephalitis with prominent parkinsonism: Clinical and FDG-PET correlates in two patients. J. Neurol. 2021;268:3980&#x2013;3987. doi: 10.1007/s00415-021-10560-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10560-3</ArticleId><ArticleId IdType="pmc">PMC8059684</ArticleId><ArticleId IdType="pubmed">33884450</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiraboschi P., Xhani R., Zerbi S.M., Corso A., Martinelli I., Fusi L., Grampa G., Lombardo A., Cavalcante P., Cappelletti C., et al. Postinfectious Neurologic Complications in COVID-19: A Complex Case Report. J. Nucl. Med. 2021;62:1171&#x2013;1176. doi: 10.2967/jnumed.120.256099.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.120.256099</ArticleId><ArticleId IdType="pmc">PMC8833873</ArticleId><ArticleId IdType="pubmed">34016729</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A.S., Perez J.A., Gunzler S.A. Frequency of Parkinson disease following COVID-19 infection: A two-year retrospective cohort study. Park. Relat. Disord. 2023;111:105433. doi: 10.1016/j.parkreldis.2023.105433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2023.105433</ArticleId><ArticleId IdType="pubmed">37141688</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M., Yon D.K., Lee S.W., Soysal P., Koyanagi A., Jacob L., Li Y., Park J.M., Kim Y.W., Shin J.I., et al. New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis. J. Med. Virol. 2023;95:e28909. doi: 10.1002/jmv.28909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28909</ArticleId><ArticleId IdType="pubmed">37394783</ArticleId></ArticleIdList></Reference><Reference><Citation>Fearon C., Fasano A. Parkinson&#x2019;s Disease and the COVID-19 Pandemic. J. Parkinson&#x2019;s Dis. 2021;11:431&#x2013;444. doi: 10.3233/JPD-202320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202320</ArticleId><ArticleId IdType="pmc">PMC8150477</ArticleId><ArticleId IdType="pubmed">33492244</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadi M., Kaburis M., Schnapper Y., Reina G., Molero P., Molendijk M.L. SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: Systematic review with frequentist and Bayesian meta-analyses. Br. J. Psychiatry. 2023;223:348&#x2013;361. doi: 10.1192/bjp.2023.43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2023.43</ArticleId><ArticleId IdType="pubmed">37183681</ArticleId></ArticleIdList></Reference><Reference><Citation>Przytu&#x142;a F., Kasprzak J., Dulski J., Koziorowski D., Kwa&#x15b;niak-Butowska M., So&#x142;tan W., Roszmann A., &#x15a;mi&#x142;owska K., Schinwelski M., S&#x142;awek J. Morbidity and severity of COVID-19 in patients with Parkinson&#x2019;s disease treated with amantadine&#x2014;A multicenter, retrospective, observational study. Park. Relat. Disord. 2023;106:105238. doi: 10.1016/j.parkreldis.2022.105238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2022.105238</ArticleId><ArticleId IdType="pmc">PMC9724557</ArticleId><ArticleId IdType="pubmed">36509028</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambergo-Michilot D., Barros-Sevillano S., Rivera-Torrej&#xf3;n O., De la Cruz-Ku G.A., Custodio N. Factors associated with COVID-19 in people with Parkinson&#x2019;s disease: A systematic review and meta-analysis. Eur. J. Neurol. 2021;28:3467&#x2013;3477. doi: 10.1111/ene.14912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14912</ArticleId><ArticleId IdType="pmc">PMC8239569</ArticleId><ArticleId IdType="pubmed">33983673</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Qushayri A.E., Ghozy S., Reda A., Kamel A.M.A., Abbas A.S., Dmytriw A.A. The impact of Parkinson&#x2019;s disease on manifestations and outcomes of COVID-19 patients: A systematic review and meta-analysis. Rev. Med. Virol. 2022;32:e2278. doi: 10.1002/rmv.2278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2278</ArticleId><ArticleId IdType="pmc">PMC8420424</ArticleId><ArticleId IdType="pubmed">34260773</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoshnood R.J., Zali A., Tafreshinejad A., Ghajarzadeh M., Ebrahimi N., Safari S., Mirmosayyeb O. Parkinson&#x2019;s disease and COVID-19: A systematic review and meta-analysis. Neurol. Sci. 2021:1&#x2013;9. doi: 10.1007/s10072-021-05756-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05756-4</ArticleId><ArticleId IdType="pmc">PMC8596358</ArticleId><ArticleId IdType="pubmed">34787753</ArticleId></ArticleIdList></Reference><Reference><Citation>Artusi C.A., Romagnolo A., Ledda C., Zibetti M., Rizzone M.G., Montanaro E., Bozzali M., Lopiano L. COVID-19 and Parkinson&#x2019;s Disease: What Do We Know So Far? J. Parkinson&#x2019;s Dis. 2021;11:445&#x2013;454. doi: 10.3233/JPD-202463.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202463</ArticleId><ArticleId IdType="pmc">PMC8150504</ArticleId><ArticleId IdType="pubmed">33749619</ArticleId></ArticleIdList></Reference><Reference><Citation>Afraie M., Moradi G., Mohammadzedeh P., Azami M., Riyahifar S., Moradi Y. COVID-19 and Parkinson&#x2019;s disease: A systematic review and meta-analysis. Acta Neurol. Belg. 2022:1&#x2013;15. doi: 10.1007/s13760-022-02141-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-022-02141-6</ArticleId><ArticleId IdType="pmc">PMC9668237</ArticleId><ArticleId IdType="pubmed">36385247</ArticleId></ArticleIdList></Reference><Reference><Citation>Rukavina K., McConvey V., Ray Chaudhuri K., Miyasaki J. Parkinson&#x2019;s disease and COVID-19: Is there an impact of ethnicity and the need for palliative care. Int. Rev. Neurobiol. 2022;165:229&#x2013;249. doi: 10.1016/bs.irn.2022.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2022.03.004</ArticleId><ArticleId IdType="pmc">PMC9042419</ArticleId><ArticleId IdType="pubmed">36208902</ArticleId></ArticleIdList></Reference><Reference><Citation>Umemura A., Oeda T., Tomita S., Hayashi R., Kohsaka M., Park K., Sugiyama H., Sawada H. Delirium and high fever are associated with subacute motor deterioration in Parkinson disease: A nested case-control study. PLoS ONE. 2014;9:e94944. doi: 10.1371/journal.pone.0094944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0094944</ArticleId><ArticleId IdType="pmc">PMC4041721</ArticleId><ArticleId IdType="pubmed">24887491</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown E.G., Chahine L.M., Goldman S.M., Korell M., Mann E., Kinel D.R., Arnedo V., Marek K.L., Tanner C.M. The Effect of the COVID-19 Pandemic on People with Parkinson&#x2019;s Disease. J. Parkinson&#x2019;s Dis. 2020;10:1365&#x2013;1377. doi: 10.3233/JPD-202249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202249</ArticleId><ArticleId IdType="pmc">PMC7683050</ArticleId><ArticleId IdType="pubmed">32925107</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Garc&#xed;a D., Oreiro M., P&#xe9;rez P., Fanjul G., Paz Gonz&#xe1;lez J.M., Feal Painceiras M.J., Cores Bartolom&#xe9; C., Vald&#xe9;s Aymerich L., Garc&#xed;a Sancho C., Castellanos Rodrigo M.D.M. Impact of Coronavirus Disease 2019 Pandemic on Parkinson&#x2019;s Disease: A Cross-Sectional Survey of 568 Spanish Patients. Mov. Disord. 2020;35:1712&#x2013;1716. doi: 10.1002/mds.28261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28261</ArticleId><ArticleId IdType="pmc">PMC7436468</ArticleId><ArticleId IdType="pubmed">32776601</ArticleId></ArticleIdList></Reference><Reference><Citation>Cilia R., Bonvegna S., Straccia G., Andreasi N.G., Elia A.E., Romito L.M., Devigili G., Cereda E., Eleopra R. Effects of COVID-19 on Parkinson&#x2019;s Disease Clinical Features: A Community-Based Case-Control Study. Mov. Disord. 2020;35:1287&#x2013;1292. doi: 10.1002/mds.28170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28170</ArticleId><ArticleId IdType="pmc">PMC7280741</ArticleId><ArticleId IdType="pubmed">32449528</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonini A., Leta V., Teo J., Chaudhuri K.R. Outcome of Parkinson&#x2019;s Disease Patients Affected by COVID-19. Mov. Disord. Off. J. Mov. Disord. Soc. 2020;35:905&#x2013;908. doi: 10.1002/mds.28104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28104</ArticleId><ArticleId IdType="pmc">PMC7267273</ArticleId><ArticleId IdType="pubmed">32347572</ArticleId></ArticleIdList></Reference><Reference><Citation>Artusi C.A., Romagnolo A., Imbalzano G., Marchet A., Zibetti M., Rizzone M.G., Lopiano L. COVID-19 in Parkinson&#x2019;s disease: Report on prevalence and outcome. Park. Relat. Disord. 2020;80:7&#x2013;9. doi: 10.1016/j.parkreldis.2020.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2020.09.008</ArticleId><ArticleId IdType="pmc">PMC7474816</ArticleId><ArticleId IdType="pubmed">32920322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hainque E., Grabli D. Rapid worsening in Parkinson&#x2019;s disease may hide COVID-19 infection. Park. Relat. Disord. 2020;75:126&#x2013;127. doi: 10.1016/j.parkreldis.2020.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7205634</ArticleId><ArticleId IdType="pubmed">32414669</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Prete E., Francesconi A., Palermo G., Mazzucchi S., Frosini D., Morganti R., Coleschi P., Raglione L.M., Vanni P., Ramat S., et al. Prevalence and impact of COVID-19 in Parkinson&#x2019;s disease: Evidence from a multi-center survey in Tuscany region. J. Neurol. 2021;268:1179&#x2013;1187. doi: 10.1007/s00415-020-10002-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10002-6</ArticleId><ArticleId IdType="pmc">PMC7471534</ArticleId><ArticleId IdType="pubmed">32880722</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Surface M., Chan A.K., Halpern J., Vanegas-Arroyave N., Ford B., Feeney M.P., Kwei K.T., Katus L.E., Kuo S.H., et al. COVID-19 manifestations in people with Parkinson&#x2019;s disease: A USA cohort. J. Neurol. 2021:1&#x2013;7. doi: 10.1007/s00415-021-10784-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10784-3</ArticleId><ArticleId IdType="pmc">PMC8418279</ArticleId><ArticleId IdType="pubmed">34482434</ArticleId></ArticleIdList></Reference><Reference><Citation>Palermo G., Tommasini L., Baldacci F., Del Prete E., Siciliano G., Ceravolo R. Impact of Coronavirus Disease 2019 Pandemic on Cognition in Parkinson&#x2019;s Disease. Mov. Disord. 2020;35:1717&#x2013;1718. doi: 10.1002/mds.28254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28254</ArticleId><ArticleId IdType="pmc">PMC7436666</ArticleId><ArticleId IdType="pubmed">32776602</ArticleId></ArticleIdList></Reference><Reference><Citation>Luis-Mart&#xed;nez R., Di Marco R., Weis L., Cianci V., Pistonesi F., Baba A., Carecchio M., Biundo R., Tedesco C., Masiero S., et al. Impact of social and mobility restrictions in Parkinson&#x2019;s disease during COVID-19 lockdown. BMC Neurol. 2021;21:332. doi: 10.1186/s12883-021-02364-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-021-02364-9</ArticleId><ArticleId IdType="pmc">PMC8404403</ArticleId><ArticleId IdType="pubmed">34461838</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Y., Kou L., Zhang G., Han C., Hu J., Wan F., Yin S., Sun Y., Wu J., Li Y., et al. Investigation on sleep and mental health of patients with Parkinson&#x2019;s disease during the Coronavirus disease 2019 pandemic. Sleep Med. 2020;75:428&#x2013;433. doi: 10.1016/j.sleep.2020.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2020.09.011</ArticleId><ArticleId IdType="pmc">PMC7481072</ArticleId><ArticleId IdType="pubmed">32980664</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalash A., Roushdy T., Essam M., Fathy M., Dawood N.L., Abushady E.M., Elrassas H., Helmi A., Hamid E. Mental Health, Physical Activity, and Quality of Life in Parkinson&#x2019;s Disease During COVID-19 Pandemic. Mov. Disord. 2020;35:1097&#x2013;1099. doi: 10.1002/mds.28134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28134</ArticleId><ArticleId IdType="pmc">PMC7276909</ArticleId><ArticleId IdType="pubmed">32428342</ArticleId></ArticleIdList></Reference><Reference><Citation>Montanaro E., Artusi C.A., Rosano C., Boschetto C., Imbalzano G., Romagnolo A., Bozzali M., Rizzone M.G., Zibetti M., Lopiano L. Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic. Neurol. Sci. 2022;43:341&#x2013;348. doi: 10.1007/s10072-021-05286-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05286-z</ArticleId><ArticleId IdType="pmc">PMC8096160</ArticleId><ArticleId IdType="pubmed">33948763</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirinzi T., Cerroni R., Di Lazzaro G., Liguori C., Scalise S., Bovenzi R., Conti M., Garasto E., Mercuri N.B., Pierantozzi M., et al. Self-reported needs of patients with Parkinson&#x2019;s disease during COVID-19 emergency in Italy. Neurol. Sci. 2020;41:1373&#x2013;1375. doi: 10.1007/s10072-020-04442-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04442-1</ArticleId><ArticleId IdType="pmc">PMC7196180</ArticleId><ArticleId IdType="pubmed">32363506</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xd8;rmann Thomsen T., Wallerstedt S.M., Winge K., Bergquist F. Life with Parkinson&#x2019;s Disease during the COVID-19 Pandemic: The Pressure Is &#x201c;OFF&#x201d;. J. Parkinson&#x2019;s Dis. 2021;11:491&#x2013;495. doi: 10.3233/JPD-202342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202342</ArticleId><ArticleId IdType="pubmed">33459663</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N., Gupta R., Kumar H., Mehta S., Rajan R., Kumar D., Kandadai R.M., Desai S., Wadia P., Basu P., et al. Impact of home confinement during COVID-19 pandemic on sleep parameters in Parkinson&#x2019;s disease. Sleep Med. 2021;77:15&#x2013;22. doi: 10.1016/j.sleep.2020.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2020.11.021</ArticleId><ArticleId IdType="pmc">PMC7682933</ArticleId><ArticleId IdType="pubmed">33302094</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heide A., Meinders M.J., Bloem B.R., Helmich R.C. The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson&#x2019;s Disease. J. Parkinson&#x2019;s Dis. 2020;10:1355&#x2013;1364. doi: 10.3233/JPD-202251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202251</ArticleId><ArticleId IdType="pmc">PMC7683090</ArticleId><ArticleId IdType="pubmed">32925108</ArticleId></ArticleIdList></Reference><Reference><Citation>van Wamelen D.J., Wan Y.M., Ray Chaudhuri K., Jenner P. Stress and cortisol in Parkinson&#x2019;s disease. Int. Rev. Neurobiol. 2020;152:131&#x2013;156. doi: 10.1016/bs.irn.2020.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2020.01.005</ArticleId><ArticleId IdType="pubmed">32450994</ArticleId></ArticleIdList></Reference><Reference><Citation>McDaniels B., Subramanian I. Social isolation, loneliness and mental health sequelae of the COVID-19 pandemic in Parkinson&#x2019;s disease. Int. Rev. Neurobiol. 2022;165:197&#x2013;227. doi: 10.1016/bs.irn.2022.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2022.03.003</ArticleId><ArticleId IdType="pmc">PMC9034749</ArticleId><ArticleId IdType="pubmed">36208901</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff A.W., Haller B., Demleitner A.F., P&#xfc;rner D., Niederschweiberer J., Cordts I., Westenberg E., Lingor P. Long-Lasting Impact of the COVID-19 Pandemic on Patients with Parkinson&#x2019;s Disease and Their Relatives. Mov. Disord. Clin. Pract. 2023;10:819&#x2013;823. doi: 10.1002/mdc3.13727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.13727</ArticleId><ArticleId IdType="pmc">PMC10187008</ArticleId><ArticleId IdType="pubmed">37205245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ineichen C., Vogel-Baumann H., Sitzler M., Deuschl G., Baumann C.R. Worsening of Parkinson&#x2019;s Disease after Termination of COVID-19 Quarantine Cannot Be Reversed Despite Resumption of Physiotherapy. J. Parkinson&#x2019;s Dis. 2023;13:845&#x2013;848. doi: 10.3233/JPD-230061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-230061</ArticleId><ArticleId IdType="pmc">PMC10473119</ArticleId><ArticleId IdType="pubmed">37270811</ArticleId></ArticleIdList></Reference><Reference><Citation>Leta V., Rodr&#xed;guez-Violante M., Abundes A., Rukavina K., Teo J.T., Falup-Pecurariu C., Irincu L., Rota S., Bhidayasiri R., Storch A., et al. Parkinson&#x2019;s Disease and Post-COVID-19 Syndrome: The Parkinson&#x2019;s Long-COVID Spectrum. Mov. Disord. 2021;36:1287&#x2013;1289. doi: 10.1002/mds.28622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28622</ArticleId><ArticleId IdType="pmc">PMC8250675</ArticleId><ArticleId IdType="pubmed">33890344</ArticleId></ArticleIdList></Reference><Reference><Citation>Bougea A., Georgakopoulou V.E., Palkopoulou M., Efthymiopoulou E., Angelopoulou E., Spandidos D.A., Zikos P. New-onset non-motor symptoms in patients with Parkinson&#x2019;s disease and post-COVID-19 syndrome: A prospective cross-sectional study. Med. Int. 2023;3:23. doi: 10.3892/mi.2023.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mi.2023.83</ArticleId><ArticleId IdType="pmc">PMC10192951</ArticleId><ArticleId IdType="pubmed">37214229</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgakopoulou V.E., Gkoufa A., Bougea A., Basoulis D., Tsakanikas A., Makrodimitri S., Karamanakos G., Spandidos D.A., Angelopoulou E., Sipsas N.V. Characteristics and outcomes of elderly patients with Parkinson&#x2019;s disease hospitalized due to COVID-19-associated pneumonia. Med. Int. 2023;3:34. doi: 10.3892/mi.2023.94.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mi.2023.94</ArticleId><ArticleId IdType="pmc">PMC10336924</ArticleId><ArticleId IdType="pubmed">37448768</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari M., Etemadifar M., Zali A., Aminzade Z., Navalpotro-Gomez I., Fateh S.T. COVID-19 in Parkinson&#x2019;s Disease treated by drugs or brain stimulation. Neurologia. 2021 doi: 10.1016/j.nrl.2021.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2021.07.002</ArticleId><ArticleId IdType="pubmed">34511276</ArticleId></ArticleIdList></Reference><Reference><Citation>Putri C., Hariyanto T.I., Hananto J.E., Christian K., Situmeang R.F.V., Kurniawan A. Parkinson&#x2019;s disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression. Park. Relat. Disord. 2021;87:155&#x2013;161. doi: 10.1016/j.parkreldis.2021.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2021.04.019</ArticleId><ArticleId IdType="pmc">PMC8065236</ArticleId><ArticleId IdType="pubmed">33931304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorrell L., Leta V., Barnett A., Stevens K., King A., Inches J., Kobylecki C., Walker R., Chaudhuri K.R., Martin H., et al. Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study. PLoS ONE. 2023;18:e0285349. doi: 10.1371/journal.pone.0285349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0285349</ArticleId><ArticleId IdType="pmc">PMC10389727</ArticleId><ArticleId IdType="pubmed">37523365</ArticleId></ArticleIdList></Reference><Reference><Citation>Roszmann A., Podlewska A.M., Lau Y.H., Boura I., Hand A. COVID-19 and Parkinson&#x2019;s disease: Nursing care, vaccination and impact on advanced therapies. Int. Rev. Neurobiol. 2022;165:173&#x2013;196. doi: 10.1016/bs.irn.2022.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2022.04.005</ArticleId><ArticleId IdType="pmc">PMC9270873</ArticleId><ArticleId IdType="pubmed">36208900</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloem B.R., Trenkwalder C., Sanchez-Ferro A., Kalia L.V., Alcalay R., Chiang H.L., Kang U.J., Goetz C., Brundin P., Papa S.M. COVID-19 Vaccination for Persons with Parkinson&#x2019;s Disease: Light at the End of the Tunnel? J. Parkinson&#x2019;s Dis. 2021;11:3&#x2013;8. doi: 10.3233/JPD-212573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-212573</ArticleId><ArticleId IdType="pmc">PMC7990445</ArticleId><ArticleId IdType="pubmed">33523021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabat R., Dayton O.L., Agarwal A., Vedam-Mai V. Analyzing the effect of the COVID-19 vaccine on Parkinson&#x2019;s disease symptoms. Front. Immunol. 2023;14:1158364. doi: 10.3389/fimmu.2023.1158364.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1158364</ArticleId><ArticleId IdType="pmc">PMC10278957</ArticleId><ArticleId IdType="pubmed">37342344</ArticleId></ArticleIdList></Reference><Reference><Citation>Erro R., Buonomo A.R., Barone P., Pellecchia M.T. Severe Dyskinesia after Administration of SARS-CoV-2 mRNA Vaccine in Parkinson&#x2019;s Disease. Mov. Disord. 2021;36:2219. doi: 10.1002/mds.28772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28772</ArticleId><ArticleId IdType="pmc">PMC8441657</ArticleId><ArticleId IdType="pubmed">34368991</ArticleId></ArticleIdList></Reference><Reference><Citation>Imbalzano G., Ledda C., Artusi C.A., Romagnolo A., Montanaro E., Rizzone M.G., Lopiano L., Zibetti M. SARS-CoV-2 vaccination, Parkinson&#x2019;s disease, and other movement disorders: Case series and short literature review. Neurol. Sci. 2022;43:5165&#x2013;5168. doi: 10.1007/s10072-022-06182-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06182-w</ArticleId><ArticleId IdType="pmc">PMC9167915</ArticleId><ArticleId IdType="pubmed">35666352</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosentino C., Torres L., V&#xe9;lez M., Nu&#xf1;ez Y., S&#xe1;nchez D., Armas C., Alvarado M. SARS-CoV-2 Vaccines and Motor Symptoms in Parkinson&#x2019;s Disease. Mov. Disord. 2022;37:233. doi: 10.1002/mds.28851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28851</ArticleId><ArticleId IdType="pmc">PMC8661843</ArticleId><ArticleId IdType="pubmed">34775612</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasano A., Cereda E., Barichella M., Cassani E., Ferri V., Zecchinelli A.L., Pezzoli G. COVID-19 in Parkinson&#x2019;s Disease Patients Living in Lombardy, Italy. Mov. Disord. Off. J. Mov. Disord. Soc. 2020;35:1089&#x2013;1093. doi: 10.1002/mds.28176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28176</ArticleId><ArticleId IdType="pmc">PMC7300944</ArticleId><ArticleId IdType="pubmed">32484584</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzam A.Y., Ghozy S., Azab M.A. Vitamin D and its&#x2019; role in Parkinson&#x2019;s disease patients with SARS-CoV-2 infection. A review article. Interdiscip. Neurosurg. 2022;27:101441. doi: 10.1016/j.inat.2021.101441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.inat.2021.101441</ArticleId><ArticleId IdType="pmc">PMC8627384</ArticleId><ArticleId IdType="pubmed">34868885</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulzer D., Antonini A., Leta V., Nordvig A., Smeyne R.J., Goldman J.E., Al-Dalahmah O., Zecca L., Sette A., Bubacco L., et al. COVID-19 and possible links with Parkinson&#x2019;s disease and parkinsonism: From bench to bedside. NPJ Parkinson&#x2019;s Dis. 2020;6:18. doi: 10.1038/s41531-020-00123-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-020-00123-0</ArticleId><ArticleId IdType="pmc">PMC7441399</ArticleId><ArticleId IdType="pubmed">32885037</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmi A., Boura I., Raeder V., Mathew D., Sulzer D., Goldman J.E., Leta V. COVID-19, nervous system pathology, and Parkinson&#x2019;s disease: Bench to bedside. Int. Rev. Neurobiol. 2022;165:17&#x2013;34. doi: 10.1016/bs.irn.2022.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2022.06.006</ArticleId><ArticleId IdType="pmc">PMC9361071</ArticleId><ArticleId IdType="pubmed">36208899</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmi A., Rizzo S., Barzon L., Sandre M., Carturan E., Sinigaglia A., Riccetti S., Della Barbera M., Boscolo-Berto R., Cocco P., et al. Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei. NPJ Parkinson&#x2019;s Dis. 2023;9:25. doi: 10.1038/s41531-023-00467-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-023-00467-3</ArticleId><ArticleId IdType="pmc">PMC9924897</ArticleId><ArticleId IdType="pubmed">36781876</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J.P., Schr&#xf6;der A.S., Edler C., Mushumba H., Fitzek A., Allweiss L., Dandri M., et al. Neuropathology of patients with COVID-19 in Germany: A post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Yoo S.J., Clijsters M., Backaert W., Vanstapel A., Speleman K., Lietaer C., Choi S., Hether T.D., Marcelis L., et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell. 2021;184:5932&#x2013;5949.e15. doi: 10.1016/j.cell.2021.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.027</ArticleId><ArticleId IdType="pmc">PMC8564600</ArticleId><ArticleId IdType="pubmed">34798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazhytska M., Kodra A., Hoagland D.A., Frere J., Fullard J.F., Shayya H., McArthur N.G., Moeller R., Uhl S., Omer A.D., et al. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell. 2022;185:1052&#x2013;1064.e12. doi: 10.1016/j.cell.2022.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.024</ArticleId><ArticleId IdType="pmc">PMC8808699</ArticleId><ArticleId IdType="pubmed">35180380</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach T.G., White C.L., 3rd, Hladik C.L., Sabbagh M.N., Connor D.J., Shill H.A., Sue L.I., Sasse J., Bachalakuri J., Henry-Watson J., et al. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol. 2009;117:169&#x2013;174. doi: 10.1007/s00401-008-0450-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0450-7</ArticleId><ArticleId IdType="pmc">PMC2631085</ArticleId><ArticleId IdType="pubmed">18982334</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann D.H., Tsukahara T., Weinreb C., Lipovsek M., Van den Berge K., Gong B., Chance R., Macaulay I.C., Chou H.J., Fletcher R.B., et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 2020;6:eabc5801. doi: 10.1126/sciadv.abc5801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5801</ArticleId><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Beauchamp L.C., Finkelstein D.I., Bush A.I., Evans A.H., Barnham K.J. Parkinsonism as a Third Wave of the COVID-19 Pandemic? J. Parkinson&#x2019;s Dis. 2020;10:1343&#x2013;1353. doi: 10.3233/JPD-202211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202211</ArticleId><ArticleId IdType="pmc">PMC7683045</ArticleId><ArticleId IdType="pubmed">32986683</ArticleId></ArticleIdList></Reference><Reference><Citation>Brundin P., Nath A., Beckham J.D. Is COVID-19 a Perfect Storm for Parkinson&#x2019;s Disease? Trends Neurosci. 2020;43:931&#x2013;933. doi: 10.1016/j.tins.2020.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.10.009</ArticleId><ArticleId IdType="pmc">PMC7577682</ArticleId><ArticleId IdType="pubmed">33158605</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingelhoefer L., Reichmann H. Pathogenesis of Parkinson disease&#x2014;The gut-brain axis and environmental factors. Nat. Rev. Neurol. 2015;11:625&#x2013;636. doi: 10.1038/nrneurol.2015.197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.197</ArticleId><ArticleId IdType="pubmed">26503923</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowaiye A.B., Okpalefe O.A., Onuh Adejoke O., Ogidigo J.O., Hannah Oladipo O., Ogu A.C., Oli A.N., Olofinase S., Onyekwere O., Rabiu Abubakar A., et al. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J. Inflamm. Res. 2021;14:1487&#x2013;1510. doi: 10.2147/JIR.S301784.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S301784</ArticleId><ArticleId IdType="pmc">PMC8057798</ArticleId><ArticleId IdType="pubmed">33889008</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds J.L., Mahajan S.D. SARS-CoV-2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation. J. Neuroimmune Pharmacol. 2021;16:4&#x2013;6. doi: 10.1007/s11481-020-09975-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-020-09975-y</ArticleId><ArticleId IdType="pmc">PMC7786155</ArticleId><ArticleId IdType="pubmed">33405097</ArticleId></ArticleIdList></Reference><Reference><Citation>Almutairi M.M., Sivandzade F., Albekairi T.H., Alqahtani F., Cucullo L. Neuroinflammation and Its Impact on the Pathogenesis of COVID-19. Front. Med. 2021;8:745789. doi: 10.3389/fmed.2021.745789.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.745789</ArticleId><ArticleId IdType="pmc">PMC8652056</ArticleId><ArticleId IdType="pubmed">34901061</ArticleId></ArticleIdList></Reference><Reference><Citation>Pissadaki E.K., Bolam J.P. The energy cost of action potential propagation in dopamine neurons: Clues to susceptibility in Parkinson&#x2019;s disease. Front. Comput. Neurosci. 2013;7:13. doi: 10.3389/fncom.2013.00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncom.2013.00013</ArticleId><ArticleId IdType="pmc">PMC3600574</ArticleId><ArticleId IdType="pubmed">23515615</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurink B., Roos E., Radonic T., Barbe E., Bouman C.S.C., de Boer H.H., de Bree G.J., Bulle E.B., Aronica E.M., Florquin S., et al. Viral presence and immunopathology in patients with lethal COVID-19: A prospective autopsy cohort study. Lancet Microbe. 2020;1:e290&#x2013;e299. doi: 10.1016/S2666-5247(20)30144-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30144-0</ArticleId><ArticleId IdType="pmc">PMC7518879</ArticleId><ArticleId IdType="pubmed">33015653</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Ismail M.Y., Diamond A., Kapoor S., Arafah Y., Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb. Res. 2020;194:101&#x2013;115. doi: 10.1016/j.thromres.2020.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.06.029</ArticleId><ArticleId IdType="pmc">PMC7305763</ArticleId><ArticleId IdType="pubmed">32788101</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulzer D. Multiple hit hypotheses for dopamine neuron loss in Parkinson&#x2019;s disease. Trends Neurosci. 2007;30:244&#x2013;250. doi: 10.1016/j.tins.2007.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2007.03.009</ArticleId><ArticleId IdType="pubmed">17418429</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkes C.H., Del Tredici K., Braak H. Parkinson&#x2019;s disease: A dual-hit hypothesis. Neuropathol. Appl. Neurobiol. 2007;33:599&#x2013;614. doi: 10.1111/j.1365-2990.2007.00874.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2007.00874.x</ArticleId><ArticleId IdType="pmc">PMC7194308</ArticleId><ArticleId IdType="pubmed">17961138</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsui J.K., Calne D.B., Wang Y., Schulzer M., Marion S.A. Occupational risk factors in Parkinson&#x2019;s disease. Can. J. Public Health. 1999;90:334&#x2013;337. doi: 10.1007/BF03404523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03404523</ArticleId><ArticleId IdType="pmc">PMC6979620</ArticleId><ArticleId IdType="pubmed">10570579</ArticleId></ArticleIdList></Reference><Reference><Citation>Merello M., Bhatia K.P., Obeso J.A. SARS-CoV-2 and the risk of Parkinson&#x2019;s disease: Facts and fantasy. Lancet Neurol. 2021;20:94&#x2013;95. doi: 10.1016/S1474-4422(20)30442-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30442-7</ArticleId><ArticleId IdType="pmc">PMC7834123</ArticleId><ArticleId IdType="pubmed">33253627</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckers M., Bloem B.R., Helmich R.C. Mask on, Mask off: Subclinical Parkinson&#x2019;s Disease Unveiled by COVID-19. J. Mov. Disord. 2023;16:55&#x2013;58. doi: 10.14802/jmd.22067.</Citation><ArticleIdList><ArticleId IdType="doi">10.14802/jmd.22067</ArticleId><ArticleId IdType="pmc">PMC9978266</ArticleId><ArticleId IdType="pubmed">36353805</ArticleId></ArticleIdList></Reference><Reference><Citation>Beatman E.L., Massey A., Shives K.D., Burrack K.S., Chamanian M., Morrison T.E., Beckham J.D. Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain. J. Virol. 2015;90:2767&#x2013;2782. doi: 10.1128/JVI.02949-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02949-15</ArticleId><ArticleId IdType="pmc">PMC4810656</ArticleId><ArticleId IdType="pubmed">26719256</ArticleId></ArticleIdList></Reference><Reference><Citation>Monogue B., Chen Y., Sparks H., Behbehani R., Chai A., Rajic A.J., Massey A., Kleinschmidt-Demasters B.K., Vermeren M., Kunath T., et al. Alpha-synuclein supports type 1 interferon signalling in neurons and brain tissue. Brain. 2022;145:3622&#x2013;3636. doi: 10.1093/brain/awac192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac192</ArticleId><ArticleId IdType="pmc">PMC10233298</ArticleId><ArticleId IdType="pubmed">35858675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Zhang X., Huang Z., Ma K. SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro. Int. J. Mol. Sci. 2022;23:3394. doi: 10.3390/ijms23063394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23063394</ArticleId><ArticleId IdType="pmc">PMC8949667</ArticleId><ArticleId IdType="pubmed">35328814</ArticleId></ArticleIdList></Reference><Reference><Citation>Semerdzhiev S.A., Fakhree M.A.A., Segers-Nolten I., Blum C., Claessens M. Interactions between SARS-CoV-2 N-Protein and &#x3b1;-Synuclein Accelerate Amyloid Formation. ACS Chem. Neurosci. 2022;13:143&#x2013;150. doi: 10.1021/acschemneuro.1c00666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00666</ArticleId><ArticleId IdType="pmc">PMC8739828</ArticleId><ArticleId IdType="pubmed">34860005</ArticleId></ArticleIdList></Reference><Reference><Citation>Outeiro T.F., Krisko A. Reply to: &#x201c;Parkinson&#x2019;s Disease and COVID-19: Do We Need to Be More Patient? &#x201d; Mov. Disord. 2021;36:278&#x2013;279. doi: 10.1002/mds.28482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28482</ArticleId><ArticleId IdType="pmc">PMC8013411</ArticleId><ArticleId IdType="pubmed">33599004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mysiris D.S., Vavougios G.D., Karamichali E., Papoutsopoulou S., Stavrou V.T., Papayianni E., Boutlas S., Mavridis T., Foka P., Zarogiannis S.G., et al. Post-COVID-19 Parkinsonism and Parkinson&#x2019;s Disease Pathogenesis: The Exosomal Cargo Hypothesis. Int. J. Mol. Sci. 2022;23:9739. doi: 10.3390/ijms23179739.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23179739</ArticleId><ArticleId IdType="pmc">PMC9456372</ArticleId><ArticleId IdType="pubmed">36077138</ArticleId></ArticleIdList></Reference><Reference><Citation>Boura I., Batzu L., Dietrichs E., Ray Chaudhuri K. Treatment paradigms in Parkinson&#x2019;s Disease and COVID-19. Int. Rev. Neurobiol. 2022;165:135&#x2013;171. doi: 10.1016/bs.irn.2022.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2022.03.002</ArticleId><ArticleId IdType="pmc">PMC9148185</ArticleId><ArticleId IdType="pubmed">36208898</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugger F., Erro R., Balint B., K&#xe4;gi G., Barone P., Bhatia K.P. Why is there motor deterioration in Parkinson&#x2019;s disease during systemic infections-a hypothetical view. NPJ Parkinson&#x2019;s Dis. 2015;1:15014. doi: 10.1038/npjparkd.2015.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npjparkd.2015.14</ArticleId><ArticleId IdType="pmc">PMC5516617</ArticleId><ArticleId IdType="pubmed">28725683</ArticleId></ArticleIdList></Reference><Reference><Citation>Nataf S. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19. J. Med. Virol. 2020;92:1743&#x2013;1744. doi: 10.1002/jmv.25826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25826</ArticleId><ArticleId IdType="pmc">PMC7228370</ArticleId><ArticleId IdType="pubmed">32246784</ArticleId></ArticleIdList></Reference><Reference><Citation>Mpekoulis G., Frakolaki E., Taka S., Ioannidis A., Vassiliou A.G., Kalliampakou K.I., Patas K., Karakasiliotis I., Aidinis V., Chatzipanagiotou S., et al. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform. PLoS ONE. 2021;16:e0253458. doi: 10.1371/journal.pone.0253458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253458</ArticleId><ArticleId IdType="pmc">PMC8241096</ArticleId><ArticleId IdType="pubmed">34185793</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>